Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Coller

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Clinical Research|September 1, 1989
The newly dead as research subjectsB S Coller
Annals of the New York Academy of Sciences|January 1, 1987
Blood elements at surfaces: plateletsB S Coller
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1992
Economic benefits of biomedical research supportB S Coller
Annals of the New York Academy of Sciences|January 1, 1983
Biochemical and electrostatic considerations in primary platelet aggregationB S Coller
Thrombosis and Haemostasis|December 22, 1999
Binding of abciximab to alpha V beta 3 and activated alpha M beta 2 receptors: with a review of platelet-leukocyte interactionsB S Coller
The Journal of Invasive Cardiology|September 5, 1994
Current concepts of thrombosisB S Coller
Circulation|November 1, 1995
Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategyB S Coller
Blood|May 1, 1981
Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agentsB S Coller
The Journal of Clinical Investigation|April 1, 1997
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeuticsB S Coller
Journal of Thrombosis and Haemostasis : JTH|July 8, 2015
αIIbβ3: structure and functionB S Coller
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Clinical Research|September 1, 1989
The newly dead as research subjectsB S Coller
Annals of the New York Academy of Sciences|January 1, 1987
Blood elements at surfaces: plateletsB S Coller
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1992
Economic benefits of biomedical research supportB S Coller
Annals of the New York Academy of Sciences|January 1, 1983
Biochemical and electrostatic considerations in primary platelet aggregationB S Coller
Thrombosis and Haemostasis|December 22, 1999
Binding of abciximab to alpha V beta 3 and activated alpha M beta 2 receptors: with a review of platelet-leukocyte interactionsB S Coller
The Journal of Invasive Cardiology|September 5, 1994
Current concepts of thrombosisB S Coller
Circulation|November 1, 1995
Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategyB S Coller
Blood|May 1, 1981
Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agentsB S Coller
The Journal of Clinical Investigation|April 1, 1997
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeuticsB S Coller
Journal of Thrombosis and Haemostasis : JTH|July 8, 2015
αIIbβ3: structure and functionB S Coller
Pageof 17